Roche

Top-Feature

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Lilly Deutschland GmbH
Photo
Roche Group
SchüllerConsulting
Photo
Lonza AG
Thomson Reuters
F. Hoffmann-La Roche Ltd
Photo
Bachem
Dishman Europe Ltd.
Styron Europe GmbH
Novartis International AG
GlobalData
LISA Life Science Austria
Novartis Vaccines and Diagnostics GmbH & Co.KG
Scienceindustries - Wirtschaftsverband Chemie Pharma Life Sciences
Photo
Arthur D. Little
Photo
CHEManager International c/o Wiley-VCH GmbH
Bayer AG - Pharmaceuticals Communications & Health Policy
Photo
GlaxoSmithKline (GSK) plc
Datamonitor Group